Judge Finds Novo's Prandin Patent Invalid
Law360 (January 19, 2011, 3:36 PM EST) -- A federal judge Wednesday found the patent for Novo Nordisk A/S diabetes drug Prandin invalid because of obviousness and unenforceable due to inequitable conduct, paving the way for Caraco Pharmaceutical Laboratories...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
